76. Chipps, B.E., Bacharier, L., and Harder, J. Phenotypic Expressions of Childhood Wheezing and Asthma: Implications for Therapy. Journal of Pediatrics 2011; (158)6: 878-884. View

75. Chipps, B.E., Zeiger, R., Murphy, K., Mellon, M., Schatz, M., Kosinski, M., Lampl, K., and Ramachandran, S. Longitudinal Validation of Test for Respiratory and Asthma Control in Kids (TRACK™) in Pediatric Practices. Pediatrics 2011; 127: e737-e747. View

74. Sicherer, S.H., Mahr, T.A, and The Section on Allergy and Immunology. Clinical Report- Management of Food Allergy in the School Setting. Pediatrics 2010; 1232-39. View

73. Haselkorn, T., Szefler, S.J., Simons, F.E., Mink, D.R., Chipps, B.E., Borish, L., and Wong, D.A. Allergy, Serum immunoglobulin E, and Airflow in Children and Adolescents in Pediatric Allergy Immunol 2010;21: 1157– 1165. View

72. Andrew H. Liu, Robert S. Zeiger, PhD, Christine A. Sorkness, Nancy K. Ostrom, Bradley E. Chipps, Kathleen Rosa, Maria E. Watson, Michael S. Kaplan, John R. Meurer, Todd A. Mahr, Michael S. Blaiss, Elisabeth Piault- Louis, Jeffrey McDonald. The Childhood Asthma Control Test©1: Retrospective determination and clinical validation of a cut-point to identify children with very poorly controlled asthma. J Allergy Clin Immunol 2010;126:267-273. View

71. Nemr S. Eid, MD, Michael J. Noonan, MD, Bradley Chipps, MD, Bhash Parasuraman, PhD, Christopher J. Miller, Christopher D. O’Brien, MD, PhD. Once vs Twice-Daily Budesonide/Formoterol in 6-15 Year Olds With Stable Asthma: A Randomized Controlled Trial. Pediatrics 2010; 126(3): e565-e575. View

70. Chipps B.E. Evaluation of Infants and Children with Refractory Lower Respiratory Symptoms. An Allergy Asthma Immunol. 2010; 104: 279-283. View

***Updated 1/13/2021***


COVID Vaccine Update

Click Here to learn more

We do not expect to be a site for administration of the COVID19 vaccine.  Please check with your local public health department.

Use this link for more information on the state of California’s tiered system for vaccine administration.


Due to current recommendations made by the US Government/CDC – The Following will go into effect until further notice.

Within the health care community as a whole, there has been an overall increase in the number of patients not seeking necessary medical treatment due to concerns about COVID-19.

If you have a medical problem, please contact your health care provider. It’s important not to delay seeking treatment when you need it.

We are currently open for in-office visits and will continue to offer telemedicine visits moving forward. We understand you might have concerns about coming in to see your health care provider. We want you to know about the steps we are taking to ensure your safety and help prevent the spread of infection:

o Mandatory Masking – All patients and visitors must be masked while in any of our care sites. Please wear a mask or face covering when you enter our facility.

o Limiting Individuals at Appointments – We will limit who is present at a patient visit. Only the patient will be allowed into the facility. If the patient is a minor, only one parent/guardian will be allowed to accompany the patient.

o Temperature Checks – All patients (and parent/guardian if patient is a minor) will have their temperatures checked at the door. Anyone with a temperature of 100 degrees or higher will be asked to reschedule their appointment or conduct the appointment via telemedicine.

o Employee Screening – We’ve instituted mandatory employee temperature screenings before each shift.

New Injection Hours – Effective 7/6/2020

Folsom Office
Monday 8:00-11:45 / 1-4:45
Tuesday Closed
Wednesday 8:00-11:45 / 1-4:45
Thursday 8:00-11:45 / 1-4:45
Friday 8:00-11:45 / 1-4:45

Roseville Office
Monday 9:00-11:45 / 1-4:45
Tuesday 8:00-11:45 / 1-4:45
Wednesday 8:00-11:45 / 1-4:45
Thursday 8:00-11:45 / 1-5:45
Friday 8:00-11:45 / 1-4:45

Monday 9:00-4:45
Tuesday 8:00-5:45
Wednesday 8:00-4:45
Thursday 9:00-4:45
Friday 8:00-4:45